Form 4 for OM Outset Medical, Inc.
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-11 · accession 0001484612-22-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-14 | 2022-11-11 | OM | Vazquez Martin | COO | S - Sale+OE | $20.00 | -15.0K | 49.5K | -23% | -$300.0K |
| DM | 2022-11-14 | 2022-11-11 | OM | Vazquez Martin | COO | M - OptEx | $3.88 | +15.0K | 54.5K | +38% | +$58.2K |
| DM | 2022-11-14 | 2022-11-11 | OM | Vazquez Martin | COO | M - OptEx | $0.00 | -15.0K | 93.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | S | D | 370 | $20.00 | 49,550 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-11 | M | A | 370 | $3.88 | 49,920 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-11 | S | D | 4,630 | $20.00 | 49,550 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-11 | M | A | 4,630 | $3.88 | 54,180 | D | — | — | |
| 5 | Common | Common Stock | 2022-11-11 | S | D | 5,000 | $20.00 | 49,550 | D | — | — | |
| 6 | Common | Common Stock | 2022-11-11 | M | A | 5,000 | $3.88 | 54,550 | D | — | — | |
| 7 | Common | Common Stock | 2022-11-11 | S | D | 5,000 | $20.00 | 49,550 | D | — | — | |
| 8 | Common | Common Stock | 2022-11-11 | M | A | 5,000 | $3.88 | 54,550 | D | — | — | (F1) Includes 573 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c). |
| 9 | Derivative | Performance Options (right to buy) | 2022-11-11 | M | D | 370 | $0.00 | 83,007 | D | $3.88 · — to 2027-12-19 | 370 Common Stock | (F3) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |
| 10 | Derivative | Performance Options (right to buy) | 2022-11-11 | M | D | 4,630 | $0.00 | 83,377 | D | $3.88 · — to 2027-12-19 | 4,630 Common Stock | (F3) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |
| 11 | Derivative | Performance Options (right to buy) | 2022-11-11 | M | D | 5,000 | $0.00 | 88,007 | D | $3.88 · — to 2027-12-19 | 5,000 Common Stock | (F3) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |
| 12 | Derivative | Performance Options (right to buy) | 2022-11-11 | M | D | 5,000 | $0.00 | 93,007 | D | $3.88 · — to 2027-12-19 | 5,000 Common Stock | (F3) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |